Cantor Fitzgerald Maintains Overweight on Trulieve Cannabis, Lowers Price Target to $41

Cantor Fitzgerald analyst Pablo Zuanic maintains Trulieve Cannabis (OTC:TCNNF) with a Overweight and lowers the price target from $51 to $41.